Gene · 2255
NIH grants2,505
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 2,505
Download this page as JSON| Grant | Title | FGF10 papers | Newest fiscal year |
|---|---|---|---|
| R01HL155150 | Bcl11b: A Master Transcription Factor Controlling Human NK Cell Development | 1 | 2025 |
| R01HL158965 | Gene regulatory networks in early lung epithelial cell fate decisions | 1 | 2025 |
| R01HL165301 | Etiology and pathogenesis of lethal lung developmental disorders in neonates | 1 | 2025 |
| R01HL166139 | Functional interrogation of a novel SCGB3A2+/SFTPB+ cell in the human airway | 1 | 2025 |
| R01HL172903 | Using guided differentiation to predict cancer treatment related cardiotoxicity | 1 | 2025 |
| R01LM012806 | Predicting Phenotype by Deep Learning Heterogeneous Multi-Omics Data | 1 | 2025 |
| R01MH126676 | Development and function of hypothalamic Lhx6-positive neurons | 1 | 2025 |
| R01NS059690 | Molecular Chaperones and Small Molecules | 1 | 2025 |
| R01NS086794 | Molecular and genetic studies of NMNAT2 in neuroprotection | 1 | 2025 |
| R01NS127895 | Tissue Engineered Nigrostriatal Pathway for Anatomical Tract Reconstruction in Parkinson's Disease | 1 | 2025 |
| R25MD007610 | The CDU-Clinical Research Education and Career Development Program | 1 | 2025 |
| R35CA197588 | Role of Phosphoinositides and Protein Kinases in the control of Cancer Metabolism | 1 | 2025 |
| R35CA232105 | Precision microRNA medicine in cancer | 1 | 2025 |
| R35CA252978 | The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer | 1 | 2025 |
| R35CA252982 | Towards targeting the lymphoma microenvironment | 1 | 2025 |
| R35ES030443 | Bioactive lipids as effectors and indicators of the deleterious effects of environmental exposure on chronic diseases | 1 | 2025 |
| R35GM118173 | Chemical Synthesis of Complex Natural Products for Translational Science | 1 | 2025 |
| R35GM119437 | Dynamics of Ligand Binding and Protein Kinase Regulation | 1 | 2025 |
| R35GM119461 | MODELING EMERGENT BEHAVIORS IN SYSTEMS BIOLOGY: A BIOLOGICAL PHYSICS APPROACH | 1 | 2025 |
| R35GM122517 | Structural Bioinformatics of Proteins and Protein Complexes and Applications to Cancer Biology | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2255/grants?page=17